Verax Biomedical

About Verax Biomedical

Verax Biomedical is a privately held, venture-backed medical products company founded in 1999, specializing in the development of rapid tests for bacterial contamination in blood components. The company's flagship product, the Platelet PGD Test, is the only FDA-cleared rapid test that enables 7-day platelet dating, significantly improving the safety and availability of platelet transfusions. Verax serves hospitals, blood banks, and transfusion centers, operating primarily in the healthcare and medical products market. The business model revolves around the sale of its proprietary testing kits and related services, generating revenue through direct sales and agreements with purchasing groups. The company is supported by a Medical Advisory Committee comprising experts in transfusion medicine, who provide guidance on product design and clinical trial planning. Verax Biomedical's management team boasts extensive experience in the medical products industry, ensuring robust leadership and strategic direction.